Skip to main content
Experimental & Molecular Medicine logoLink to Experimental & Molecular Medicine
. 2024 Oct 28;56(10):2324. doi: 10.1038/s12276-024-01343-7

Author Correction: Ablation of the deubiquitinase USP15 ameliorates nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

Jung-Hwan Baek 1,#, Myung Sup Kim 1,#, Hye Ryeon Jung 2, Min-Seon Hwang 1, Chan-ho Lee 1, Dai Hoon Han 3, Yong-ho Lee 4, Eugene C Yi 2, Seung-Soon Im 5, Ilseon Hwang 6, Kyungeun Kim 7, Joon-Yong Chung 8, Kyung-Hee Chun 1,
PMCID: PMC11542037  PMID: 39468328

Correction to: Experimental & Molecular Medicine 10.1038/s12276-023-01036-7, published online 03 July 2023

After online publication of this article, the authors noticed an error in the Acknowledgements section.

The correct statement of this article should have read as below.

“This study was supported by the Bio & Medical Technology Development Program of the National Research Foundation of Korea (NRF) funded by the Korean government (NRF 2021M3A9E4021818 and NRF-2022M3A9G8082639), the NRF grant awarded by the Korean government (NRF-2022R1A2C2007300) and a faculty research grant of Yonsei University College of Medicine (6-2021-0080)”

The authors apologize for any inconvenience caused.

The original article has been corrected.


Articles from Experimental & Molecular Medicine are provided here courtesy of Korean Society for Biochemistry and Molecular Biology

RESOURCES